Specialities

Specialities

Respiratory Infections
Airway Diseases
Allergy
Asthma
Bronchiectasis
Bronchitis
Chronic Cough
COPD
COVID-19
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Interventional Pulmonology
Lung Cancer
Paediatric Respiratory Medicine
Respiratory Tract Disorders
Pulmonary Embolism
Pulmonary Hypertension
Respiratory Intensive Care
Rhinosinusitis
Sleep Related Breathing Disorders
Lung Transplantation and Surgery
Ventilation
Lung Health
Rare Diseases
Search

Trending Topic
4 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Foreword – touchREVIEWS in Respiratory & Pulmonary Diseases, Volume 9, Issue 1, 2024

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

touchREVIEWS in Respiratory & Pulmonary Diseases. 2024;9(1):1-2

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchRESPIRATORY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
99 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES

Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease

Dr Helena Yu, Dr Antonio Passaro, Dr Aaron Lisberg, Dr Sara Pilotto, Ms Jackie Fenemore, Prof. Egbert Smit

Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.

Translations available:
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT

Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors

Dr Lizza Hendriks, Dr Jacob Sands, Prof. Suresh Senan

A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).

Translations available:
55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT

Precision targeting of MET in NSCLC: A multidisciplinary approach

Dr Xiuning Le, Dr Christine Argento, Dr Sandra Cuellar, Ms Stephanie McDonald, Prof. Albrecht Stenzinger

A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment

Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar

Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

Translations available:
41 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Expanding HER2 horizons: Implications for NSCLC and beyond

Dr Razelle Kurzrock, Dr Lyudmila Bazhenova, Dr Ignacio Wistuba

Two oncologists and a pathologist discuss the implications of HER2 targeting in solid tumours, with a focus on NSCLC.

Translations available:
37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies

Prof. Enriqueta Felip, Prof. Keith Kerr

An oncologist and a pathologist discuss HER2 testing and treatments for HER2-altered NSCLC.

Translations available:
33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Immunotherapy for early-stage, resectable NSCLC: From clinical trial data to guidelines

Prof. Heather A Wakelee

Prof. Wakelee discusses the latest evidence on immunotherapy for early-stage, resectable NSCLC.

Translations available:
31 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Optimizing management of bronchiolitis obliterans syndrome: Current strategies, future directions

Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono

Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

Translations available:
15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Current treatments and unmet needs in limited-stage small cell lung cancer

Dr Anne Chiang

A medical oncologist shares her insights on the current treatments for LS-SCLC and the remaining unmet needs

Society & Congress Partners

touchRESPIRATORY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All
16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Expert insights in food allergy: Considerations for diagnosis and management in primary care and beyond

Dr Antonella Cianferoni

An allergist shares her expert insights on the latest guidance for the diagnosis and management of food allergies, including the role of novel diagnostic tools and emerging therapies in clinical practice.

34 minutes
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchTALKS

Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs

Dr Rebecca Heist

Dr Rebecca Heist discusses emerging antibody-drug conjugates for the second-line treatment of patients with advanced non-small cell lung cancer.

Translations available:
16 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Addressing the diagnosis and management of pet allergies in primary care and beyond

Dr Ann-Marie Malby Schoos

An allergist shares her expert insights and guidance on key clinical questions around the changing paradigm in the diagnosis and management of pet allergies.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Diagnosing and treating patients with EoE: Tackling the difficulties

Dr Efrem Eren, Dr Nirmala Gonsalves, Dr Jamal Hayat

Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.

Translations available:
18 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchFOCUS

Overcoming challenges in advanced or metastatic squamous cell lung cancer: Focus on immunotherapy

Dr Balazs Halmos

Dr Balazs Halmos offers his perspective on immunotherapy for the treatment of squamous cell lung cancer.

38 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Personalized therapy for NSCLC: Biomarker testing, treatment and management in the presence of MET alterations

Prof. Paul Paik, Dr Yasushi Goto

Two lung cancer specialists discuss the current recommendations for biomarker testing and the latest data on MET inhibitors for the management of patients with MET alterations.

Translations available:
32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

The mRNA vaccine platform: A novel tool for the rapid development of vaccines against respiratory viral infections

Dr Anna Blakney, Prof. Dr. med. Oliver Cornely, Prof. Ann R Falsey

Leading experts explore mRNA vaccine platforms for respiratory viruses, including their design, clinical application and future prospects.

Translations available:
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Contemporary insights on the management of sickle cell disease: Focus on complications and recent advances in therapy

Prof. Biree Andemariam, Prof. Modupe Idowu, Prof. Mark C Walters

Three experts discuss the management of complications of sickle cell disease, as well as recent advances in therapy.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

Current and future considerations for the use of immune checkpoint inhibitors in non-small cell lung cancer

Dr Pilar Garrido

A leading expert discusses the current landscape and future perspectives of immune checkpoint inhibitors for the treatment of NSCLC

Load More...

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Latest Medical Education - straight to your inbox

Close Popup